Wang Julia Aijun
SEC CIK 1860279 · EDGAR
BoughtSold
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
| 14 | Wang Julia Aijun | CFO, EVP | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Wang Julia Aijun | CFO, EVP | M - OptEx | — | +860 | 2,062 | +72% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Wang Julia Aijun | CFO, EVP | F - Tax | $289.89 | -245 | 1,817 | -12% | -$71.0K |
| D | 2026-02-10 | 2026-02-06 | LH | Labcorp | Wang Julia Aijun | CFO, EVP | F - Tax | $277.20 | -254 | 1,202 | -17% | -$70.4K |
| D | 2026-02-10 | 2026-02-06 | LH | Labcorp | Wang Julia Aijun | CFO, EVP | M - OptEx | — | +893 | 1,456 | +159% | — |
| D | 2025-02-10 | 2025-02-06 | LH | Labcorp | Wang Julia Aijun | CFO, EVP | F - Tax | $247.74 | -336 | 557 | -38% | -$83.2K |
| D | 2025-02-10 | 2025-02-06 | LH | Labcorp | Wang Julia Aijun | CFO, EVP | M - OptEx | — | +893 | 893 | New | — |
| 2024-07-03 | 2024-07-01 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $143.90 | -472 | 0 | -100% | -$67.9K | |
| 2024-06-26 | 2024-06-24 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $155.66 | -899 | 0 | -100% | -$139.9K | |
| M | 2024-06-20 | 2024-06-17 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $159.04 | -916 | 762 | -55% | -$145.7K |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | A - Grant | $0.00 | +136.2K | 456.3K | +43% | $0 |
| 2024-03-04 | 2024-02-29 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $167.08 | -397 | 0 | -100% | -$66.3K | |
| 2023-07-06 | 2023-07-03 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $179.55 | -472 | 0 | -100% | -$84.7K | |
| 2023-06-27 | 2023-06-23 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $182.85 | -840 | 0 | -100% | -$153.6K | |
| D | 2023-06-20 | 2023-06-20 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $192.54 | -190 | 0 | -100% | -$36.6K |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | A - Grant | $0.00 | +107.8K | 342.3K | +46% | $0 |
| 2023-03-03 | 2023-03-01 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $240.21 | -343 | 0 | -100% | -$82.4K | |
| A | 2022-07-18 | 2022-07-01 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $158.50 | -317 | 0 | -100% | -$50.2K |
| 2022-07-05 | 2022-07-01 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $158.50 | -295 | 0 | -100% | -$46.8K | |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | A - Grant | $0.00 | +104.4K | 245.6K | +74% | $0 |
| 2022-06-21 | 2022-06-17 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $136.64 | -161 | 0 | -100% | -$22.0K | |
| 2022-03-02 | 2022-02-28 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | A - Grant | $0.00 | +61.8K | 143.3K | +76% | $0 | |
| 2021-07-01 | 2021-07-01 | ONC | BeOne Medicines Ltd. | Wang Julia Aijun | CFO | S - Sale | $349.06 | -308 | 0 | -100% | -$107.5K |
Purchase Sale Sale after option exercise All abbreviations